EPT-17PHASE I STUDY OF BRAF INHIBITOR (VEMURAFENIB) IN COMBINATION WITH THE MTOR INHIBITOR (EVEROLIMUS) IN BRAFV600EPOSITIVE CHILDHOOD AND AYA BRAIN TUMORS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.